Deparine, Adelaida D.
HRN: 28-26-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/16/2025
12/23/2025
IV
4.5
Q8
Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes